Shandong Hualu-Hengsheng Chemical Co., Ltd. Overview
Hualu-Hengsheng is China's benchmark low-cost coal-to-chemicals producer. It runs a flexible multi-product syngas platform ("一头多线、柔性联产") built on clean-coal gasification. From one feedstock it produces more than 40 products across four segments: (1) new-energy and new-materials chemicals (DMC, oxalic/dibasic acids, 2-ethylhexanol, adipic acid, caprolactam, nylon-6, BDO/NMP); (2) nitrogen fertilizer (urea); (3) organic amines (DMF and methylamines); and (4) acetic acid and derivatives. The company describes itself as the world's largest DMC supplier and the world's largest DMF producer [AR25-S via NBD-0326]. Since 2021 it has moved from a single site in Dezhou (Shandong) to a "twin carrier" ("双航母") model, adding a second integrated base in Jingzhou (Hubei) that is 70% owned. Its competitive edge is structural cost leadership. That edge widens when crude oil is expensive relative to coal, as in H1 2026. The main pressures on it are domestic overcapacity, carbon constraints on coal chemicals, and product-price cyclicality.
Company's own description (FY2025 / H1 2026 reports, paraphrased)
The company describes itself as a "comprehensive multi-product co-production chemical enterprise" (多业联产的综合型化工企业) [AR25-S; H1-26]. Its licensed scope covers:
-
basic chemical raw materials
-
chemical and specialty chemical products
-
fertilizer production and sales
-
synthetic materials
-
hazardous-chemical production and trading
-
power generation and supply
-
heat and steam supply
-
coal and coal-product sales, added to the articles in March 2025 [AR24-S]
The four reporting product lines are new-energy/new-materials related products, chemical fertilizers, organic amines, and acetic acid and derivatives [H1-26].
The operating model has three pillars, as described in [H1-26]:
Production: intrinsic safety, environmental protection, high quality, continuous optimisation and lean management. Clean-coal gasification is used to build a "flexible multi-co-production operating mode".
Procurement: "transparent full-process procurement" with strategic supplier relationships, a strict supplier-access regime and source-level purchasing.
Marketing: "cooperation creates value; co-opetition creates win-win", focused on quality, integrity, brand and service.
Independent characterisation
| Supplier | Prepayment (CNY Mn) | Share of prepayments |
|---|---|---|
| Shaanxi Coal Transportation & Marketing Group Jianhong Investment | 257.2 | 37.7% |
| Shaanxi Future Energy Chemical | 77.8 | — |
| Yankuang Energy (Ordos) | 54.5 | — |
| Product | End uses |
|---|---|
| DMC | Lithium-battery electrolyte solvent; polycarbonate feedstock; developer solutions; pharmaceuticals; precursor to EMC/DEC electrolyte solvents |
| Dibasic (oxalic) acid | New energy, rare-earth separation, pharmaceuticals |
| 2-Ethylhexanol (octanol) | Plasticiser raw material and solvent |
| Adipic acid | Nylon-66, polyurethane, 1,6-hexanediol, TPU, powder coatings |
| Caprolactam | Nylon-6 high-speed spinning and conventional chips, MC nylon |
| Nylon-6 chips | Filament yarn, engineering plastics, industrial yarn, BOPA film, staple fibre |
| Urea | Agriculture and industrial uses |
| DMF | Polar solvent for chemicals, pharmaceuticals, electronics and PU leather |
| Acetic acid | Acetate esters, PTA, vinyl acetate, chloroacetic acid, glycine |
Business model. Hualu-Hengsheng is a pure product business: it sells commodity and semi-specialty chemicals. Service, subscription and licensing revenue is essentially nil. Small "other business" income comes from by-products, steam sales and leasing; it was RMB 186.1M in H1 2026, or 1.1% of revenue [H1-26].
How value is created.
-
Coal is gasified into syngas (CO + H₂). Syngas becomes ammonia, methanol and CO.
-
These platform molecules are steered toward whichever downstream chain has the best margin at the time: urea, DMF/methylamines, acetic acid, ethylene glycol / oxalate chain, DMC/EMC, or oxo-alcohols.
-
Purchased benzene and propylene feed the adipic acid / caprolactam / nylon-6 and 2-ethylhexanol chains.
-
The main input costs are thermal and raw coal (sourced from Shaanxi and Inner Mongolia suppliers), benzene and propylene.
-
In FY2025 the purchase price ranges were raw coal RMB 600–810/t, benzene RMB 4,560–7,230/t and propylene RMB 5,150–6,470/t [OPS25].
Value-chain position. The company sits in the mid-stream as a basic and intermediate chemicals converter. Upstream, it buys rather than owns coal. Its five largest prepayment counterparties at 30 Jun 2026 were:
Source: [H1-26]. Downstream, its products go into a wide range of industrial and agricultural chains.
Customer types and end-markets.
Source: [H1-26].
Customer concentration.
-
In FY2021 the top five customers were 10.17% of sales and the top five suppliers were 33.41% of purchases [CS-2203].
-
Exports were 4.6% of H1 2026 revenue (RMB 795.4M) [H1-26].
-
The largest receivable counterparties at 30 Jun 2026 were overseas polyurethane and chemical buyers, which fits the DMF/adipic acid export profile:
-
KIMPUR UK Ltd: 27.2% of receivables
-
JMD Chemicals: 19.8%
-
KIMTEKS Poliuretan (Turkey): 10.2%
-
Methyl Co Ltd: 6.5%
-
Merino Industries: 6.1%
-
Sales terms. Domestic sales are largely cash or bank-acceptance before delivery. Receivables were only RMB 59.1M against H1 2026 revenue of RMB 17.16bn. Bank and commercial acceptance notes and e-credit instruments carried in "receivables financing" were RMB 2.68bn [H1-26].
Strategy
Stated strategic themes (FY2025 AR, as paraphrased in [NBD-0326] and [H1-26])
Core strategic framework. The company plans to use the national "de-capacity / anti-involution" drive, which is accelerating the exit of obsolete capacity, to advance four themes:
-
refreshing existing assets (存量焕新)
-
raising efficiency (效能提优)
-
coupling value chains (链条耦合)
-
upgrading products (产品升级)
The goals are to "optimise platforms, extend chains and expand clusters" and to build a model of technology-driven cost reduction, higher-end products and supply-chain synergy.
Growth pole. New energy and new materials is named as the core growth pole. Specific links include:
-
NMP for lithium-battery solvents
-
dibasic acid for new energy and rare-earth separation
-
DMC/EMC for electrolytes
Geographic model. "One body, two wings" and "twin aircraft carriers" (Dezhou plus Jingzhou).
Digital and AI. The company reports 100% digital-technology penetration in manufacturing and full automatic-control coverage. It was selected for the national first batch of excellence-level smart factories and is "actively exploring AI applications" [NBD-0326; H1-26].
H1 2026 operating priorities [H1-26]:
-
deepen market penetration and seize fertilizer exports
-
diversify marketing to escape homogeneous competition
-
dig further into cost reductions
-
accelerate project construction to cement the twin-carrier layout
Strategic initiatives (last 24 months)
| Initiative | Date | Scope / target | Status (latest) | Source |
|---|---|---|---|---|
| Gasification Platform Upgrade (德州) | Announced Aug 2025 | Budget RMB 3,039.05M; 18-month construction; scale-efficiency and cost-floor uplift | 63.16% complete; RMB 1,324M in CIP at 30 Jun 2026 | [H1-26]; [KY-0826] |
| 200kt/yr monobasic acid project | 2024–25 | Budget RMB 815.67M | 99.55% complete (H1-26) | [H1-26] |
| Melamine-resin monomer materials project | 2024–25 | Budget RMB 733.78M | 52.38% complete | [H1-26] |
| Additional 200kt dibasic acid (proposed) | 2,026 | Capacity expansion | Proposed | [KY-0826] |
| Jingzhou BDO/NMP/PBAT integration | Commissioned 23 Aug 2025 | 200/160/30kt | Ramping | [HA-1125] |
| 200kt dibasic (oxalic) acid | Commissioned 9 Sep 2025 | New-energy and rare-earth chains | Ramping (main driver of H1-26 volume) | [HA-1125]; [SMW-0926] |
| Amide raw-material optimisation upgrade | Completed 2025 | Caprolactam-chain cost reduction | Complete | [CW-0826] |
| Jingzhou capital increase | Approved 5 Dec 2025 | RMB 2.0bn pro rata (company RMB 1.4bn) to de-lever the subsidiary | RMB 1.0bn first tranche done | [H1-26] |
| Small technical upgrades | Ongoing | RMB 1,498M in CIP at 30 Jun 2026 | Ongoing | [H1-26] |
| Shareholder-return programme | 2025–26 | Buyback (7.85M shares cancelled); semi-annual dividends; 3-for-10 bonus issue | Executed | [H1-26] |
| Structured-deposit cash management | Renewed Mar 2026 | Up to RMB 2.0bn | RMB 100M outstanding at 30 Jun 2026 | [AR25-S]; [H1-26] |
| ESG governance | FY2025 | ESG Leading Group chaired by the Chairman; ESG report prepared to SSE Guideline No.14 | In place | [AR25-S] |
Guidance and medium-term targets
| Metric | Company target | Actual outcome | Source |
|---|---|---|---|
| FY2025 revenue budget | RMB 34.7bn | RMB 30.97bn (missed by 10.8%) | [AR24-S] |
| FY2026 revenue budget | RMB 33.5bn (+8.2% vs FY2025) | H1 2026 at 51% of budget | [AR25-S]; [H1-26] |
| Payout | Cash payout ≥30% in practice (FY2024 32.6%, FY2025 31.9%); three-year cumulative cash payout 100.2% of average NP | — | [AR25-S] |
| Medium-term financial targets (margins, ROE) | — | — | — |
The company warns that forward-looking statements are not commitments [AR25-S].
Products & Services
Capacities are design capacities per [H1-26] unless stated otherwise. Prices are ex-tax ranges from [OPS24]/[OPS25] or average/median prices from [CW-0826] and [KY-0826]. The company sells at market prices and discloses no list-price model. Price-list and product-specification sheets are not publicly disclosed.
New-energy & new-materials related products
| Product | Description & uses | Capacity | Start / latest expansion | FY2024 price range (MYR Bn/t) | FY2025 price range (MYR Bn/t) | 2026 data point |
|---|---|---|---|---|---|---|
| Dimethyl carbonate (DMC) | Li-ion electrolyte solvent; PC (non-phosgene) feedstock; developer; pharma; precursor to EMC/DEC. World's largest supplier per the company. | 600kt | Expanded through 2022–23 | 3,010–5,750 | 2,920–5,800 | H1-26 median RMB 4,430/t, +8.85% YoY [CW-0826] |
| Ethyl methyl carbonate (EMC) / diethyl carbonate (DEC) | Electrolyte co-solvents. Electronic grades developed in 2022. | 300kt EMC unit commissioned around Mar–Apr 2023 [CLS-2303] | 2,023 | — | — | — |
| Dibasic acid (oxalic acid, 二元酸/草酸) | New energy (e.g. battery-material precursors), rare-earth separation, pharma | 500kt | 200kt line started 9 Sep 2025 | — | — | Q2-26 oxalic acid avg RMB 4,382/t, +21.3% QoQ [KY-0826] |
| 2-Ethylhexanol (isooctanol, 异辛醇) | Plasticiser (DOTP/DOP) raw material and solvent | 200kt | — | 6,650–12,030 | 5,130–7,080 | Q2-26 octanol avg RMB 8,431/t [KY-0826] |
| Adipic acid | Nylon-66 salt, PU polyols, 1,6-HDO, TPU, powder coatings | 526.6kt | 200kt Dezhou unit 2024 | 6,800–9,300 | 5,300–8,400 | H1-26 median RMB 7,875/t, +14.96% [CW-0826] |
| Caprolactam (CPL) | Nylon-6 high-speed and conventional spinning chips; MC nylon | 300kt | Amide & nylon project around 2021–22; amide raw-material upgrade 2025 | 9,200–12,390 | 7,120–9,960 | Q2-26 avg RMB 12,077–12,563/t [GS-0826; KY-0826] |
| Nylon-6 (PA6) chips | Filament yarn, engineering plastics, industrial yarn, BOPA film, staple | 200kt | 2,022 | 9,910–13,980 | 7,610–10,360 | — |
| 1,4-Butanediol (BDO) | PBT, PU, THF/PTMEG, GBL→NMP feedstock | 200kt (Jingzhou) | Started 23 Aug 2025 | — | — | Q2-26 avg RMB 8,139/t [KY-0826] |
| N-methyl-pyrrolidone (NMP) | Li-ion cathode-slurry solvent | 160kt (Jingzhou) | Started 23 Aug 2025 | — | — | — |
| PBAT | Biodegradable polyester | 30kt (Jingzhou) | Started 23 Aug 2025 | — | — | — |
| Ethylene glycol (coal-based) † | Polyester feedstock | Not disclosed in H1-26 product list | Legacy (2010s) | — | — | — |
Chemical fertilizers
| Product | Description | Capacity | Notes | FY2024 price range | FY2025 price range | 2026 data point |
|---|---|---|---|---|---|---|
| Urea | Nitrogen fertilizer for agriculture; industrial uses (AdBlue/DEF, resins) | 3,070kt | Includes Jingzhou phase-2 520kt (2024) | 1,510–2,570 | 1,390–2,060 | H1-26 median RMB 1,660/t, -5.41% YoY; Q2-26 market avg RMB 1,869/t [CW-0826; GS-0826] |
| Ammonia (merchant), ammonium sulphate (by-product) | Fertilizer and industrial | — | Ammonium sulphate is a CPL by-product (480kt planned in 2019) | — | — | Q2-26 synthetic ammonia avg RMB 2,731/t [KY-0826] |
Organic amines
| Product | Description | Capacity | Notes | 2026 data point |
|---|---|---|---|---|
| DMF (dimethylformamide) | High-polarity solvent for PU leather, pharma, electronics, acrylic fibre | 480kt | World's largest producer per company | Q2-26 avg RMB 4,700/t, flat QoQ; "supply ample, margins compressed" [GS-0826] |
| Methylamines (mono-, di-, tri-) | Intermediates for DMF, pesticides, pharma, water treatment | — | Largely captive into DMF | — |
Acetic acid & derivatives
| Product | Description | Capacity | FY2024 price range | FY2025 price range | 2026 data point |
|---|---|---|---|---|---|
| Glacial acetic acid | Methanol carbonylation; used in acetate esters, PTA, VAM, chloroacetic acid, glycine | 1,500kt | 2,350–3,230 | 2,010–2,630 | H1-26 median RMB 3,255/t, +37.05% YoY [CW-0826] |
| Acetic anhydride | Cellulose acetate, pharma | — | — | — | — |
Other products and utilities
| Product | Status | Source |
|---|---|---|
| Melamine (legacy) | — | 2019–20 broker notes |
| Formic acid | 200kt planned with the 2019 nylon project | 2019–20 broker notes |
| Melamine-resin monomer materials | Project under construction: budget RMB 733.78M, 52.38% complete at 30 Jun 2026 | [H1-26] |
| 200kt/yr "monobasic acid" (一元酸) project | 99.55% complete at 30 Jun 2026; budget RMB 815.67M | [H1-26] |
| Steam / power | Steam sold to the related-party Dezhou Thermal Power; RMB 28.6M in H1 2026 | [H1-26] |
Financial Narrative
All figures are in RMB millions unless the row label says otherwise. Sources by year:
-
FY2021: [CS-2203]
-
FY2022: [AR24-S] 3-year table and [CLS-2303]
-
FY2023–FY2025: [AR24-S], [AR25-S]
-
Expense and balance-sheet detail FY2024–25: [GS-0826] and [KY-0826], which reproduce reported statements
Income statement
Revenue CAGR FY2021–FY2025 (derived): +3.8% per year. Attributable NP CAGR FY2021–FY2025 (derived): -17.8% per year.
EPS comparability. Following the July 2026 3-for-10 bonus issue, brokers restate FY2025 EPS to RMB 1.21 and FY2024 to RMB 1.42 on the 2.75bn-share base [KY-0826]. Guosen still shows RMB 1.56 for FY2025 [GS-0826]. Readers should check which share base a source uses.
DPS detail.
Quarterly trajectory: notes and sources
Sources: [AR24-S]; [AR25-S]; Q1-26 from Tencent News; Q2-26 from [GS-0826]. Q2-26 OCF is derived as H1 RMB 2,692M minus Q1 RMB 891M.
Balance sheet
Notes on sources:
-
FY2024 current-portion figure is Guosen's "short-term borrowings & trading liabilities" line [GS-0826]. Kaiyuan shows short-term borrowings of zero for FY2024 [KY-0826].
-
FY2025 current portion of LT borrowings is from [H1-26] comparatives.
-
Working capital is per Stockstar's compilation of reported data.
Cash flow
Notes on sources:
-
Capex is from [KY-0826]. Guosen shows RMB 5,411M for FY2024 and RMB 3,655M for FY2025 [GS-0826]; the discrepancy reflects line definitions.
-
FY2025 buyback is treasury stock held for buyback at 31 Dec 2025. Cumulative buyback cost cancelled in May 2026 was RMB 200.1M [H1-26].
-
D&A is per [KY-0826].
-
H1 2026 cash flow [H1-26]: OCF RMB 2,692M (+15.5%), capex RMB 1,656M, derived FCF RMB 1,036M. Dividends paid in cash in H1 were only RMB 159.6M because the RMB 528.8M final dividend was paid in July.
Ratios
Notes on sources and methods:
-
ROIC: FY2021 from [CS-2203]; FY2024–25 from [KY-0826]. Guosen shows 10% and 8%.
-
ROA is derived as attributable NP divided by year-end assets.
-
Interest coverage is derived as (operating profit + finance cost) divided by finance cost.
-
Asset turnover is derived using average assets.
-
Receivable days are near zero because of cash and acceptance-note terms.
Commentary — trends, inflections, drivers
1. Cycle peak to trough and back (FY2021 → FY2025).
-
FY2021 was a super-cycle peak. Revenue doubled and NP quadrupled on strong urea, DMF and acetic acid prices, with gross margin at 35.5% and ROE at 38.5% [CS-2203].
-
From FY2022 to FY2023 prices normalised. Gross margin compressed to 28.9% and then below 20%. NP fell 51% across those two years.
-
FY2024 was a volume-led recovery. Jingzhou's ramp lifted revenue +25.6% to a record RMB 34.2bn, but NP grew only 9.1% because price spreads kept narrowing [AR24-S].
-
FY2025 brought price deflation across nearly every product. Revenue fell 9.5%, but gross margin actually improved about 0.4pp to 19.2%: falling coal (raw coal RMB 600–810/t vs RMB 747–940/t in FY2024) and benzene costs offset product-price declines, and cost of sales fell 10.0% [OPS25; NBD-0326].
2. Inflection in H1 2026.
-
Attributable NP rose 50% on revenue growth of only 8.9%, because cost of sales rose just 0.8% [H1-26].
-
Q2-26 gross margin reached 25.8% [GS-0826].
-
The company attributes the improvement to "anti-involution" (反内卷) supply discipline and to the geopolitical oil shock, which the H1 report describes as the US–Israel–Iran war. Higher oil raised prices for oil-based competitors' products while Hualu's coal-based costs rose less: coal median +9.4%, against acetic acid +37% and adipic acid +15% [H1-26; CW-0826].
3. R&D step-change.
-
R&D expense rose 34% to RMB 886M in FY2025 [NBD-0326].
-
It rose a further 95% to RMB 684M expensed in H1 2026, or RMB 733M including RMB 48M capitalised [H1-26].
-
H1 R&D intensity was 3.99%, up 1.76pp [CW-0826]. Materials made up RMB 514M of the expensed amount, which points to large pilot and trial-run programmes [H1-26].
4. Balance-sheet discipline.
-
Leverage remains low: liabilities/assets 28.5% at FY2025 and net debt/EBITDA about 1.1x. This was maintained despite RMB 5.1bn of capex in FY2024 and RMB 3.65bn in FY2025.
-
The company has issued no bonds. Bank debt is mostly guaranteed by the controlling shareholder, which began charging a guarantee fee from August 2026.
5. Cash conversion.
-
OCF has tracked or exceeded attributable NP in every year shown. In FY2025 OCF was 1.27x attributable NP, helped by D&A of about RMB 3.2bn.
-
Working capital turned from negative RMB 2.4bn (FY2023) to roughly zero (FY2025) as payables to equipment vendors were settled.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Role | Ownership | Key data |
|---|---|---|---|
Shandong Hualu-Hengsheng Chemical Co., Ltd. (parent) | Dezhou integrated base | Listed | H1 2026 parent revenue RMB 12,826M; parent NP RMB 1,906M |
Hualu-Hengsheng (Jingzhou) Co., Ltd. (荆州恒升) | Second base, Jiangling, Hubei | 70% direct. Minorities (30%): HK Hualu and Hualu Investment (related parties under Hualu Holdings). | Registered capital RMB 6,000M. H1 2026: total assets RMB 19,296M, net assets RMB 8,544M, revenue RMB 4,447M, operating profit RMB 751M, NP RMB 637M. |
Segment (Company Label) Overview
| Segment (company label) | Contents | Key named products | Design capacity (H1-26) |
|---|---|---|---|
New-energy & new-materials related products (新能源新材料相关产品) | Electrolyte solvents and precursors, oxalate/dibasic acids, oxo-alcohols, nylon chain, BDO/NMP | DMC; dibasic acid; 2-EH (isooctanol); adipic acid; caprolactam; nylon-6 | DMC 600kt; dibasic acid 500kt; 2-EH 200kt; adipic acid 526.6kt; caprolactam 300kt; nylon-6 200kt |
Chemical fertilizers (化学肥料) | Nitrogen fertilizer | Urea | Urea 3,070kt |
Organic amines (有机胺系列产品) | Amide solvents and methylamines | DMF (lead product); mono-, di- and tri-methylamine | DMF 480kt |
Acetic acid & derivatives (醋酸及衍生品) | Carbonylation chain | Glacial acetic acid (lead); acetic anhydride | Acetic acid 1,500kt |
Other products / by-products | Melamine, formic acid, ammonium sulphate, liquid ammonia, steam/power and other | — | — |
“—” = not publicly disclosed.
Segment revenue (CNY Mn)
| Segment revenue (CNY Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
New-energy & new-materials related products | — | 16,433 | 15,557 |
Chemical fertilizers | — | 7,297 | 7,306 |
Organic amines | — | 2,511 | 2,361 |
Acetic acid & derivatives | — | 4,070 | 3,387 |
Other products & by-products (derived residual) | — | 3,915 | 3,388 |
Total revenue | 27,260 | 34,226 | 30,969 |
Segment YoY growth (%)
| Segment YoY growth (%) | FY2024 | FY2025 |
|---|---|---|
New-energy & new-materials related products | — | -5.3 |
Chemical fertilizers | — | 0.1 |
Organic amines | — | -6.0 |
Acetic acid & derivatives | — | -16.8 |
Total revenue | 25.6 | -9.5 |
Segment share of total revenue (%)
| Segment share of total revenue (%) | FY2024 | FY2025 |
|---|---|---|
New-energy & new-materials related products | 48.0 | 50.2 |
Chemical fertilizers | 21.3 | 23.6 |
Organic amines | 7.3 | 7.6 |
Acetic acid & derivatives | 11.9 | 10.9 |
Other | 11.4 | 10.9 |
Segment sales volume (kt)
| Segment sales volume (kt) | FY2024 | FY2025 |
|---|---|---|
New-energy & new-materials related products | 2,552 | 3,002 |
Chemical fertilizers | 4,712 | 5,752 |
Organic amines | 587 | 586 |
Acetic acid & derivatives | 1,550 | 1,562 |
H1 2026 Segment Details
| H1 2026 segment | Revenue | Cost | Gross profit (derived) | Gross margin % (derived) | YoY revenue % | Share of revenue % |
|---|---|---|---|---|---|---|
New-energy & new-materials | 9,329.3 | 7,614.0 | 1,715.4 | 18.4 | +22.43 | 54.4 |
Chemical fertilizers | 3,882.3 | 2,592.7 | 1,289.6 | 33.2 | +0.08 | 22.6 |
Organic amines | 1,155.5 | 904.9 | 250.6 | 21.7 | ≈0 | 6.7 |
Acetic acid & derivatives | 1,877.8 | 1,191.8 | 686.0 | 36.5 | +10.08 | 10.9 |
Other products | 731.5 | 549.0 | 182.5 | 24.9 | — | 4.3 |
By-products & other business | 186.1 | 174.0 | 12.2 | 6.5 | — | 1.1 |
Total | 17162.5 | 13026.4 | 4136.1 | 24.1 | +8.87 | 100 |
9m 2025 Details
| 9M 2025 | Revenue (CNY Mn) | YoY % | Sales volume (kt) | Volume YoY % |
|---|---|---|---|---|
New-energy & new-materials | 11,556 | -6.17 | 2,163.4 | +13.84 |
Chemical fertilizers | 5,826 | +11.01 | 4,332.9 | +35.45 |
Organic amines | 1,769 | -5.55 | 432.9 | +0.87 |
Acetic acid & derivatives | 2,515 | -17.49 | 1,143.8 | +1.64 |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (CNY Mn) | 26,636 | 30,245 | 27,260 | 34,226 | 30,969 |
Revenue growth (%) | 103.1 | 13.5 | -9.9 | 25.6 | -9.5 |
Cost of sales (CNY Mn) | — | — | — | 27,821 | 25,037 |
Gross profit (CNY Mn; FY21–22 derived from reported GM) | 9,453 | 8,753 | — | 6,405 | 5,932 |
R&D expense (CNY Mn) | — | — | — | 661 | 886 |
Operating profit (CNY Mn) | — | — | — | 5,008 | 4,251 |
EBITDA (CNY Mn; broker-compiled from reported data) | — | — | — | 8,315 | 8,010 |
Pre-tax profit (CNY Mn) | — | — | 4,281 | 5,015 | 4,262 |
Income tax (CNY Mn) | — | — | — | 836 | 607 |
Net profit incl. minorities (CNY Mn) | — | — | — | 4,178 | 3,656 |
Net profit attributable (CNY Mn) | 7,254 | 6,289 | 3,576 | 3,903 | 3,315 |
Attributable NP ex non-recurring (CNY Mn) | 7,212 | 6,417 | 3,703 | 3,870 | 3,288 |
EPS basic as reported (MYR Bn) | 3.43 | 2.965 | 1.689 | 1.841 | 1.563 |
EPS diluted as reported (MYR Bn) | — | 2.965 | 1.689 | 1.841 | 1.563 |
Cash DPS declared for the fiscal year (MYR Bn, pre-2026 bonus issue) | 0.80 | — | 0.60 | 0.60 | 0.50 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 35.49 | 28.94 | — | 18.71 | 19.15 |
Operating margin (%) | — | — | — | 14.63 | 13.73 |
EBITDA margin (%) | — | — | — | 24.3 | 25.9 |
Net margin attributable (%) | 27.23 | 20.79 | 13.12 | 11.40 | 10.71 |
Cash Flow History
| Fiscal year | Interim | Final | Total cash |
|---|---|---|---|
FY2023 | — | — | RMB 1,273.99M (≈RMB 0.60/sh) |
FY2024 | RMB 0.30/sh | RMB 0.30/sh | RMB 1,273.26M |
FY2025 | RMB 0.25/sh | RMB 0.25/sh | RMB 1,058.46M (31.92% payout) |
Financial Analysis
| Metric | Q1-24 | Q2-24 | Q3-24 | Q4-24 | Q1-25 | Q2-25 | Q3-25 | Q4-25 | Q1-26 | Q2-26 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue (CNY Mn) | 7,978 | 8,997 | 8,205 | 9,046 | 7,772 | 7,992 | 7,789 | 7,416 | 8,344 | 8,819 |
Attributable NP (CNY Mn) | 1,065 | 1,159 | 825 | 854 | 707 | 862 | 805 | 942 | 1,117 | 1,236 |
Operating cash flow (CNY Mn) | 1,131 | 1,778 | 983 | 1,077 | 930 | 1,401 | 967 | 899 | 891 | 1,801 |
Balance Sheet
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (CNY Mn) | — | 35,005 | 44,051 | 46,658 | 49,177 |
Cash & equivalents (CNY Mn) | — | — | — | 1,398 | 2,085 |
Short-term borrowings (CNY Mn) | — | — | — | 0 | 776 |
Current portion of LT debt (CNY Mn) | — | — | — | 1,198 | 1,973 |
Long-term borrowings (CNY Mn) | — | — | — | 8,224 | 8,139 |
Total interest-bearing debt (CNY Mn, derived) | — | — | — | 9,422 | 10,888 |
Net debt (CNY Mn, derived) | — | — | — | 8,024 | 8,803 |
Total liabilities (CNY Mn) | — | — | — | 13,830 | 14,027 |
Equity attributable (CNY Mn) | — | 26,923 | 28,891 | 31,018 | 33,080 |
Minority interests (CNY Mn) | — | — | — | 1,810 | 2,070 |
Goodwill (CNY Mn) | 0 | 0 | 0 | 0 | 0 |
Intangible assets (CNY Mn) | — | — | — | 2,367 | 2,857 |
Fixed assets (CNY Mn) | — | — | — | 30,057 | 32,994 |
Net working capital (CNY Mn) | — | — | -2,425 | -1,584 | 24 |
Financial Analysis — Total assets
| Item | CNY Mn |
|---|---|
Total assets | 51,694 |
Cash | 3,171 |
Structured deposits | 100 |
Short-term borrowings | 567 |
Current portion of LT borrowings | 2,431 |
Long-term borrowings | 8,017 (of which RMB 7,487M guaranteed by the controlling shareholder) |
Total interest-bearing debt (derived) | ≈11,015 |
Net debt (derived) | ≈7,744 |
Equity attributable | 34,933 |
Minority interests | 2,563 |
Construction in progress | 3,438 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (CNY Mn) | 4,906 | 6,999 | 4,715 | 4,968 | 4,198 |
Capex (CNY Mn) | — | — | — | 5,081 | 3,650 |
Free cash flow (CNY Mn, derived) | — | — | — | -113 | 548 |
Cash dividends declared for year (CNY Mn) | — | — | 1,274 | 1,273 | 1,058 |
Share buybacks executed (CNY Mn, approx.) | 0 | 0 | 0 | 0 | 167 |
Depreciation & amortisation (CNY Mn) | — | — | — | 2,800 | 3,226 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE weighted (%) | 38.53 | 25.58 | 12.81 | 13.05 | 10.32 |
ROIC (%) | 33.97 | — | — | 12.1 | 10.1 |
ROA (%) | — | 18.0 | 8.1 | 8.4 | 6.7 |
Current ratio (x) | — | — | — | 1.33 | 1.54 |
Debt to equity (x) | — | — | — | 0.30 | 0.33 |
Liabilities to assets (%) | — | — | — | 29.6 | 28.5 |
Net debt to EBITDA (x) | — | — | — | 0.96 | 1.10 |
Interest coverage (x) | — | — | — | 23.8 | 17.2 |
Asset turnover (x) | — | — | — | 0.75 | 0.65 |
Region revenue (CNY Mn)
| Region revenue (CNY Mn) | H1 2026 | Share of H1 2026 revenue (%) |
|---|---|---|
Domestic (Mainland China) | 16,367 | 95.4 |
Overseas (export) | 795 | 4.6 |
Total | 17,162 | 100 |
Geographic Revenue
| Base | H1 2025 revenue (CNY Mn) | H1 2026 revenue (CNY Mn) | YoY % | H1 2026 NP (CNY Mn) | NP YoY % |
|---|---|---|---|---|---|
Jingzhou, Hubei (Central China) | 4,108 | 4,447 | +8.3 | 637 | +17.7 |
Dezhou parent, Shandong (North China), standalone | 12,018 | 12,826 | +6.7 | 1,906 | +60.3 |
Share Price History
| Date | Share price (MYR Bn) | Market cap (CNY Mn) | Shares (M) | Basis | Source |
|---|---|---|---|---|---|
29 Oct 2025 | Not stated | — | 2,123 | PE TTM 16.62x; PB 1.64x; PS 1.65x | Eastmoney / CS 29 Oct 2025 |
30 Mar 2026 | 37.17 | 78,919 | 2,123 | Pre-bonus | [NBD-0326] |
19 Aug 2026 | 20.96 | 57,639 | 2,750 | Post-bonus | [GS-0826] |
24 Aug 2026 | 20.07 | 55,191 | 2,750 | Post-bonus | [KY-0826] |
52-week range to 24 Aug 2026 | 44.10 / 17.88 | — | — | Mixed adjustment basis (high likely pre-bonus) | [KY-0826] |
Valuation Multiples
| Multiple | Hualu-Hengsheng | Basis |
|---|---|---|
P/E TTM (x) | 13.5 | TTM attributable NP RMB 4,099M = FY25 3,315 − H1-25 1,569 + H1-26 2,353 |
P/E FY2026E (x) | 11.0–12.2 | Consensus of Kaiyuan, Guosen and Great Wall [KY-0826; GS-0826; CW-0826] |
P/B MRQ (x) | 1.58 | Equity attributable RMB 34,933M at 30 Jun 2026 |
EV (CNY Mn) | ≈65,600 | Mcap + debt RMB 11,015M − cash & deposits RMB 3,271M + minorities RMB 2,563M |
EV/Sales TTM (x) | 2.03 | TTM revenue RMB 32,367M |
EV/EBITDA FY2025 (x) | ≈8.2 | EBITDA RMB 8,010M [KY-0826]. Broker figures: Guosen 7.7x; Kaiyuan 8.3x. |
Peer Comparison
| Peer | FY26E PE (x) | PB (x) |
|---|---|---|
Baofeng Energy | 10.1 | 3.1 |
Luxi Chemical | 15.4 | 1.2 |
Hubei Yihua | 17.8 | 2.2 |
Hualu-Hengsheng | 12.2 | 1.7 |
Analyst Ratings & Targets
| Broker | Rating | FY2026E NP (CNY Mn) | FY2027E NP (CNY Mn) | FY2028E NP (CNY Mn) | FY2026E revenue (CNY Mn) |
|---|---|---|---|---|---|
Guosen Securities | Outperform | 4,740 | 4,958 | 5,234 | 37,209 |
Kaiyuan Securities | Buy | 5,040 | 6,009 | 6,827 | 35,813 |
Great Wall Securities | Buy | 4,770 | 5,578 | 6,418 | 36,401 |
Dividend (MYR Bn per share as declared)
| Dividend (MYR Bn per share as declared) | FY2021 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Total cash DPS declared (MYR Bn) | 0.80 | 0.60 | 0.60 | 0.50 |
Cash payout ratio (%) | — | 35.6 | 32.6 | 31.9 |
Capital Programmes
| Programme | Shares | Cost | Status |
|---|---|---|---|
April 2025 programme | 7,845,881 | ≈RMB 200M | Executed and cancelled 6 May 2026 |
Bucket Details
| Bucket | CNY Mn | Notes |
|---|---|---|
≤1 year | ≈3,004 | Short-term borrowings RMB 567M + current portion RMB 2,431M + accrued interest RMB 6M |
| 8,017 | Long-term loans; RMB 7,487M guaranteed by Shandong Hualu-Hengsheng Group |
Lease liabilities | ≈51 | Including current portion |
Analyst Conclusions
Management guidance
| Item | Detail | Source |
|---|---|---|
| FY2026 revenue budget | RMB 33.5bn (+8.2%). H1 delivered RMB 17.16bn, or 51% of budget. | [AR25-S]; [H1-26] |
| Qualitative guidance | Seize fertilizer exports, deepen strategic cooperation, push cost reductions, speed project construction, reinforce the "twin carrier" model | [H1-26] |
| Earnings guidance | No earnings guidance is given | — |
Consensus growth expectations
FY2026E: revenue RMB 35.8–37.2bn (+16–20%); attributable NP RMB 4.74–5.04bn (+43–52%) [GS-0826; KY-0826; CW-0826].
FY2027–28E: NP growth ranges from mid-single-digit (Guosen) to mid-teens (Kaiyuan, Great Wall).
Run-rate check: H1 2026 NP of RMB 2.35bn annualises to about RMB 4.7bn, consistent with the lower end of the consensus range.
Bull case
-
Coal-vs-oil spread persistence. If crude stays elevated (WTI around USD 89 in early Oct 2026), oil-based competitors continue to set higher price floors. H1-26 already shows gross margin expanding to 24.1% from 18.0% a year earlier, with cost of sales up only 0.8% on revenue up 8.9% [H1-26].
-
Volume plus cost-floor step-up. New-energy/new-materials volumes grew 16.8% in H1-26, led by oxalic acid. The RMB 3.04bn gasification upgrade, about 63% complete, should reach completion in 2027 and lower unit costs. Melamine-monomer and further dibasic-acid projects add optionality [H1-26; SMW-0926; KY-0826].
-
Undemanding valuation with rising returns. The stock trades at about 13.5x TTM and about 1.6x book, against FY2026E ROE of about 13% [GS-0826]. Low leverage (≈28% liabilities/assets) and a growing dividend (FY2026 interim +35% equivalent) support yield and re-rating potential.
Bear case
-
Overcapacity is structural, not cyclical. DMC utilisation is 54%, DMF 45%, and urea capacity exceeds demand by about 8Mt [NBD-0326]. The FY2025 revenue budget miss (RMB 30.97bn against RMB 34.7bn) shows how quickly volume gains are wiped out by pricing.
-
Windfall reversal. The H1-26 earnings rebound rests on a geopolitical oil shock. Coal is already +27% YoY in Q2-26 [KY-0826]. A Middle East de-escalation could compress spreads just as new capacity ramps. The share-price slide of about 29% (adjusted) from March to August 2026 suggests the market already doubts sustainability.
-
Rising structural costs and governance drag. The new guarantee fee to the controlling shareholder, the end of interest capitalisation (H1 finance costs +29.5%), R&D up 94.5%, possible loss of the 15% HNTE tax rate after Nov 2026, and future carbon-intensity limits all erode the cost moat at the margin [H1-26; SSE Aug 2026].
Catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable | What to watch |
|---|---|---|
| Late Oct 2026 | Q3 2026 results | Whether Q3 NP holds above RMB 1.1bn amid higher coal costs; 9M run-rate vs RMB 4.7–5.0bn consensus |
| Q4 2026 | Payment of the RMB 0.26 interim dividend | Cash return execution |
| Around Nov 2026 | Parent HNTE certificate renewal | 15% vs 25% tax rate |
| Ongoing | Brent/WTI vs Chinese thermal-coal prices | Key spread driver |
| Ongoing | Urea export-quota policy | Fertilizer upside |
| Ongoing | Oxalic acid / DMC / NMP pricing | New-energy chain economics |
| Ongoing | Gasification upgrade progress (63% at H1-26) | On-time completion around 2027 |
| Ongoing | Second RMB 1.0bn Jingzhou capital-increase tranche | Subsidiary de-leveraging |
| Ongoing | New project approvals (dibasic acid, melamine monomer) | Capex intensity vs payout |
| Ongoing | Guarantee-fee quantum | Related-party cost |
| Ongoing | 15th FYP coal-chemical carbon benchmarks | Retrofit capex risk |
| Mar 2027 | FY2026 annual report | FY2027 revenue budget; final dividend |
Concluding analyst verdict
Hualu-Hengsheng remains the highest-quality operator in China's coal-chemicals complex. It can prove the claim through the trough. In FY2025, with nearly every product priced below the prior year and the industry openly describing itself as "involuted", the company still produced:
-
RMB 3.3bn of net profit
-
RMB 4.2bn of operating cash flow
-
a 19% gross margin, about 8 points above its closest product-overlap peer
The balance sheet has absorbed more than RMB 8.7bn of capex in two years without bond issuance. In the same period the company paid out more than its average annual earnings in dividends over three years and retired 7.85M shares.
The H1 2026 rebound (+50% NP) is real but has two sources. Part of it is structural: oxalic-acid and BDO/NMP volumes, cost discipline, and a second base now earning 14% net margins. Part of it is exogenous: an oil shock that widened the coal-route advantage. The market appears to price in mainly the exogenous part. Post-bonus, the shares trade around 13x trailing and 11–12x forward earnings at roughly 1.6x book, having de-rated about 29% from March despite accelerating profits.
The downside is cushioned by a demonstrated cost floor, a payout that has grown with each interim, and modest leverage. The upside depends on three things: oil staying firm, the gasification upgrade being delivered in 2027, and "anti-involution" policy actually removing marginal capacity.
The key swing factors to monitor are:
-
the Q3 2026 margin print against rising coal
-
HNTE tax renewal
-
the scale of the new guarantee fee
-
the 15th Five-Year carbon rules
The investment case is therefore constructive but not one-way. This is a best-in-class cyclical, not a structural grower. Position size should reflect sensitivity to the oil–coal spread rather than to management execution, which remains consistently strong.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role (as disclosed) | Notes | Source |
|---|---|---|---|
Chang Huaichun (常怀春) | Chairman; legal representative; Strategy Committee convener | Also legal representative of the controlling shareholder, Shandong Hualu-Hengsheng Group (2026). Held 100,000 restricted shares (unlocked). | [H1-26]; [AR25-S] |
Qi Shaoqing (祁少卿) | Director; Strategy Committee member | Related director (recuses on related-party votes). 80,000 restricted shares. | [H1-26]; [AR24-S] |
Gao Jinghong (高景宏) | Director; principal in charge of accounting (CFO-equivalent); Nomination Committee | 80,000 restricted shares | [H1-26] |
Yu Fuhong (于富红) | Director; Strategy Committee | Also legal representative of the related party Dezhou Thermal Power | [AR25-S] |
Zhang Chengyong (张成勇) | Director; Audit Committee | Related director | [AR24-S]; [AR25-S] |
Sun Yiqian (孙一倩) | Director | Related director; 23,334 restricted shares | [H1-26] |
Guo Shaohui (郭绍辉) | Independent director; Nomination Committee convener | — | [AR24-S]; [AR25-S] |
Wu Fei (吴非) | Independent director; Remuneration Committee convener | — | [AR24-S] |
Huang Rong (黄蓉) | Independent director; Audit Committee convener | — | [AR24-S] |
Li Xingang (李新刚) | Independent director | Strategy and Nomination Committees | [AR24-S] |
Ma Jianchun (马建春) | Director (Remuneration Committee member per Mar 2025 composition) | — | [AR24-S] |
Board of Directors — Zhuang Guangshan
| Name | Title | Restricted shares |
|---|---|---|
Zhuang Guangshan (庄光山) | Senior executive; board director until 2025 | 80,000 |
Yang Zhaoying (杨召营) | Senior executive | 80,000 |
Zhang Jie (张杰) | Senior executive | 80,000 |
Gao Wenjun (高文军) | Board secretary | 33,334 |
Zhang Hucheng (张虎城) | Head of accounting department | — |
Directors' Remuneration
| Committee | Members |
|---|---|
Strategy | Chang (convener), Guo, Li, Qi, Yu |
Remuneration & Appraisal | Wu (convener), Ma, Guo |
Nomination | Guo (convener), Li, Huang, Gao Jinghong, Zhuang |
Audit | Huang (convener), Wu, Zhang Chengyong |
Major Shareholders
| # | Holder | Shares | % | Change in H1 2026 |
|---|---|---|---|---|
| 1 | Shandong Hualu-Hengsheng Group (with concert parties: Dezhou Thermal Power 41.90M, Hualu Investment 2.08M, Hualu Intl Business Center 0.32M) | 681,061,374 | 32.20 | 0 |
| 2 | HKSCC (Northbound Stock Connect) | 80,071,784 | 3.79 | +44,816,349 |
| 3 | NSSF Portfolio 106 | 53,193,958 | 2.51 | -5,500,739 |
| 4 | Zhongtai Xingyuan Value Flexible Allocation Fund | 16,850,797 | 0.80 | +2,821,429 |
| 5 | Penghua CSI Chemical Sub-industry ETF | 15,180,617 | 0.72 | -2,603,318 |
| 6 | NSSF Portfolio 103 | 13,000,000 | 0.61 | -6,000,000 |
| 7 | Basic Pension Fund Portfolio 807 | 12,771,972 | 0.60 | -7,878,429 |
| 8 | China Life – Traditional Product 005L-CT001 | 12,664,454 | 0.60 | +1,719,512 |
| 9 | Basic Pension Fund Portfolio 15022 | 12,590,238 | 0.60 | +8,608,800 |
| 10 | Harvest Fund – NSSF Portfolio 16042 | 11,785,739 | 0.56 | -3,503,200 |
Competitive Landscape
Key Competitors
| Competitor | Ticker | Overlapping segments | Verified data point | Relative positioning vs Hualu-Hengsheng |
|---|---|---|---|---|
Ningxia Baofeng Energy | 600989.SH | Coal chemicals (olefins, coking); coal-to-chemicals cost peer | Mcap RMB 173.5bn; FY2025 EPS RMB 1.56; FY2026E PE 10.1x; PB 3.1x (19 Aug 2026) [GS-0826] | Larger and olefins-focused; higher market valuation |
Luxi Chemical | 000830.SZ | Urea, DMF, caprolactam/PA6, PC, formic acid | FY2025 revenue RMB 29,143M (-2.1%); NP RMB 907M (-55.3%); gross margin 10.97%; mcap RMB 22.6bn (Lanjinger 29 Apr 2026; [GS-0826]) | Closest product-overlap peer (also Shandong). Hualu's FY2025 gross margin of 19.2% was about 8pp higher. |
Hubei Yihua Chemical | 000422.SZ | Urea, PVC, coal chemicals (Central China, close to Jingzhou) | Mcap RMB 13.7bn; FY2025 EPS RMB 0.75 [GS-0826] | Regional competitor for the Jingzhou base |
Shanghai Huayi Group | 600623.SH | Acetic acid, methanol, carbonylation | — | Major acetic acid producer (East China) |
Jiangsu Sopo / Yankuang (Yankuang Lunan, Rongxin) | — | Acetic acid | — | Large acetic acid producers |
Shida Shenghua (Shengtai) | 603026.SH | DMC and electrolyte solvents | — | DMC/EMC competitor in the Li-ion solvent chain |
Hualu's DMF peers (Zhejiang Jiangshan Chemical and others) | — | DMF | — | Hualu is the self-described global No.1 |
Huafon Chemical / Pingmei Shenma | 002064.SZ / 600810.SH | Adipic acid; nylon-66/6 | — | Large adipic acid producers |
Hengyi / Highsun / Juhua (caprolactam players) | various | Caprolactam / PA6 | — | Caprolactam capacity growth pressured CPL prices in FY2025 |
Henan Xinlianxin Chemical (Stanley Fertilizer) | 1866.HK | Urea, DMF, methanol | — | Coal-based urea/DMF peer |
Yuntianhua | 600096.SH | Fertilizers (phosphate plus nitrogen) | — | Broad fertilizer peer |
Wanhua Chemical | 600309.SH | Petrochemicals, PU, new materials | FY2025 PU revenue RMB 75.06bn, petrochemicals RMB 84.20bn, fine chemicals & new materials RMB 33.19bn (Wanhua FY2025 operating data) | Much larger diversified chemicals benchmark; oil/LPG-based rather than coal-based |
Peer Comparison FY2025
| Metric | Hualu-Hengsheng (600426) | Luxi Chemical (000830) | Baofeng Energy (600989) | Hubei Yihua (000422) |
|---|---|---|---|---|
Revenue FY2025 (CNY Mn) | 30,969 | 29,143 | — | — |
Revenue growth FY2025 (%) | -9.5 | -2.1 | — | — |
Gross margin FY2025 (%) | 19.2 | 10.97 | — | — |
Attributable NP FY2025 (CNY Mn) | 3,315 | 907 | — | — |
Net margin FY2025 (%) | 10.7 | 3.1 | — | — |
R&D intensity FY2025 (%) | 2.9 | — | — | — |
Market cap (CNY Mn, 19 Aug 2026) | 57,639 | 22,623 | 173,507 | 13,736 |
PE FY2026E (x) | 12.2 | 15.4 | 10.1 | 17.8 |
PB MRQ (x) | 1.7 | 1.2 | 3.1 | 2.2 |



